Since the coronavirus 2019 (COVID-19) crisis broke out
in Italy at the end of February 2020, days before the
World Health Organization declared the pandemic,1,2 two
crucial issues urgently emerged and needed to be
addressed by our institution. First was the containment
of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) epidemic together with the restructuring of national public and private health care to face
the spread of the new viral disease among the population. Second, central as well, was to maintain the
offer of medical and surgical treatments to the patients
who still presented with other severe diseases—of
these in particular, oncologic patients
